Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study.
Heart failure (HF) is the final outcome of virtually all cardiovascular diseases and is a major and increasingly serious public health problem. The renin-angiotensin system plays an important role in the pathogenesis of cardiovascular disease. Insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) has attracted significant attention; it has been extensively investigated in a spectrum of cardiovascular phenotypes because of its correlation with serum ACE activity. There is controversy regarding the association of ACE I/D polymorphism with cardiovascular disease. The aim of this study was to investigate whether ACE genotype is associated with HF by comparing cases and controls. The study sample consisted of 229 cases with HF due to coronary heart disease or idiopathic dilated cardiomyopathy and 230 controls recruited from the general population. The ACE I/D genotype was identified using a polymerase chain reaction assay. No evidence was found to support an association between ACE genotype and HF.
Covolo
L
L
Department of Hygiene, University of Brescia, Brescia, Italy.
Gelatti
U
U
Metra
M
M
Donato
F
F
Nodari
S
S
Pezzali
N
N
Dei Cas
L
L
Nardi
G
G
D016022:Case-Control Studies; D005260:Female; D017353:Gene Deletion; D005838:Genotype; D006333:Heart Failure / Q000235:genetics*; D006801:Humans; D015994:Incidence; D008297:Male; D016254:Mutagenesis, Insertional; D007703:Peptidyl-Dipeptidase A / Q000235:genetics* / Q000502:physiology; D011110:Polymorphism, Genetic / Q000235:genetics; D012307:Risk Factors; D012737:Sex Factors
D007703:Peptidyl-Dipeptidase A